Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study

AIM: To make efficacy and safety comparison of telbivudine-raodmap and tenofovir-roadmap in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. METHODS: This was the first prospective, randomised, two-arm, open-label, non-inferiority study in HBeAg-negative CHB patients that c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Hepatol
Auteurs principaux: Krastev, Zahari, Petrova, Diana, Kotzev, Iskren, Celen, Mustafa Kemal, Mendelson, Meryl, Chandra, Richa, Pandey, Priti, Hamed, Kamal
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2016
Sujets:
Randomized Clinical Trial
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114476/
https://ncbi.nlm.nih.gov/pubmed/27917266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v8.i32.1402
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires